Archive 2013

2013

- 20 Dec 2013 – Destiny Pharma to attend 32nd Annual J.P. Morgan Healthcare Conference, San Francisco
- 18 Nov 2013 – 6th European Antibiotic Awareness Day
- 07 Nov 2013 – Destiny Pharma to attend BioInfect 2013 Conference
- 24 Sep 2013 – Report by CDC details today’s drug-resistant health threats
- 19 Sep 2013 – UK Government publish strategy to combat antimicrobial resistance between 2013 and 2018
- 20 May 2013 – Press Release: Part 2 of NIAID-funded US clinical trial of anti-staphylococcal nasal gel XF-73 begins enrollment
- 01 Mar 2013 – Chief Medical Officer Dame Sally Davies publishes annual report providing a comprehensive overview of the threat of antimicrobial resistance and infectious diseases
- 01 Feb 2013 – New US Therapeutic Guidelines on Antimicrobial Prophylaxis published which recommend that all higher risk surgeries should now decolonise all patients with documented colonisation with S. aureus and not just MRSA
- 01 Jan 2013 – US ICU infection rate cut by 44% by Universal bacterial Decolonisation – Hospital Corporation of America (HCA) ICU’s to adopt this regimen during early 2013
- 01 Jan 2013 – Chief Medical Officer Dame Sally Davies says that antibiotic-resistant diseases pose “Apocalyptic” threat and tells MPs that the issue should be added to the UK Government’s national risk register of civil emergencies